DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

Novartis (NYSE: NVS)

company name or ticker
Company Photos
(Click to zoom)

Will Biogen Win From Novartis MS Drug Safety Label Change?

Regeneron's Knock-out Quarter Could Be Just The Beginning

Regeneron's sales and income are soaring and new drug launches could lead to even better results in the future.

Momenta Pharmaceuticals: Firing On All Cylinders

See Which Of The Latest 13F Filers Holds Novartis

Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 05, 2015

Are Things Looking Up for GlaxoSmithKline?

New drugs from the Novartis transaction help offset Advair’s declining sales; CEO highlights London-based pharma giant’s future drug pipeline.

5 Biotechs With Catalysts Coming This Week

A Post-Earnings Review Of Amgen, With Discussion Of The Repatha Launch

Novartis Completes Divestiture of Influenza Vaccines Business to CSL Limited for $275M

Amgen Beats on Q2 Earnings & Revenues, Raises Outlook - Analyst Blog

See More Articles...